Crossmark

RETRACTED ARTICLE: Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-κB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1–7 Signals

Crossref DOI link: https://doi.org/10.1007/s12011-022-03286-4

Published Online: 2022-05-19

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kamel, Esam O.

Gad-Elrab, Wail M.

Ahmed, Mohammed A.

Mohammedsaleh, Zuhair M.

Hassanein, Emad H. M.

Ali, Fares E. M.
Funding

Funding for this research was provided by:

Al-Azhar University
License Information

Text and Data Mining valid from 2022-05-19

Version of Record valid from 2022-05-19
More Information

Article History

Received: 21 February 2022

Accepted: 6 May 2022

First Online: 19 May 2022

Change Date: 15 August 2024

Change Type: Correction

Change Details: This article has been retracted. Please see the Retraction Notice for more detail:

Change Details: https://doi.org/10.1007/s12011-024-04347-6

Declarations

:

: The Faculty of Medicine Ethics Committee of Assiut University, Egypt, approved our experimental study following the “NIH Guide for the Care and Use of Laboratory Animals.”

: The authors declare no competing interests.

Document is current

Any future updates will be listed below